China Resources Medical Holdings Company Limited (1PH) — Strategic Asset Allocation Index
China Resources Medical Holdings Company Limited (1PH) has a Strategic Asset Allocation Index of 75.6% as of June 2023. Strategic assets (PP&E of €5.43 Billion plus long-term investments of €-) total €5.43 Billion, measured against net assets of €7.18 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
China Resources Medical Holdings Company Limited Strategic Asset Allocation Index (2016–2022)
This chart shows how China Resources Medical Holdings Company Limited's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 75.6%, representing strategic assets of €5.43 Billion against net assets of €7.18 Billion EUR. Explore how efficiently does China Resources Medical Holdings Company generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for China Resources Medical Holdings Company Limited (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for China Resources Medical Holdings Company Limited from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 1PH market cap.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 32.7% | €2.29 Billion | €2.29 Billion | €- | €7.00 Billion | ▲ +1.8 pp |
| 2021 | 30.9% | €2.12 Billion | €2.12 Billion | €- | €6.85 Billion | ▲ +14.5 pp |
| 2020 | 16.5% | €1.05 Billion | €1.05 Billion | €- | €6.34 Billion | ▲ +11.0 pp |
| 2019 | 5.5% | €337.43 Million | €337.43 Million | €- | €6.14 Billion | ▲ +1.0 pp |
| 2018 | 4.5% | €259.36 Million | €259.36 Million | €- | €5.71 Billion | ▼ 0.0 pp |
| 2017 | 4.6% | €256.60 Million | €256.60 Million | €- | €5.60 Billion | ▼ -0.4 pp |
| 2016 | 4.9% | €264.29 Million | €264.29 Million | €- | €5.36 Billion | — |